Company Filing History:
Years Active: 2012
Title: Anne O'Kearney-McMullan: Innovator in Pharmaceutical Chemistry
Introduction
Anne O'Kearney-McMullan is a distinguished inventor based in Macclesfield, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative chemical processes. Her work has led to advancements in the manufacture of important pharmaceutical compounds.
Latest Patents
Anne holds a patent for her invention titled "Crystalline forms of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline." This invention relates to chemical processes useful in the manufacture of the compound 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline, which is the active entity within AZD0530. The patent also covers intermediates useful in the manufacture of that compound and processes for the manufacture of those intermediates. Additionally, it relates to particular crystalline forms of that compound, such as a difumarate salt and a trihydrate, as well as pharmaceutical compositions containing such crystalline forms.
Career Highlights
Anne is currently employed at AstraZeneca AB, where she continues to push the boundaries of pharmaceutical research and development. Her innovative approach and dedication to her work have made her a valuable asset to the company and the industry as a whole.
Collaborations
Throughout her career, Anne has collaborated with notable colleagues, including James Gair Ford and James Francis McCabe. These collaborations have further enriched her research and contributed to the success of her projects.
Conclusion
Anne O'Kearney-McMullan is a remarkable inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. Her contributions continue to impact the field positively, showcasing her dedication and expertise.